Panacea Acquisition Corp. II (PANA)
|Net Income (ttm)||n/a|
|Trading Day||July 29|
|Day's Range||9.96 - 9.97|
|52-Week Range||9.90 - 10.23|
SAN FRANCISCO, CA, April 06, 2021 (GLOBE NEWSWIRE) -- Panacea Acquisition Corp. II (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition,...
Panacea Acquisition II, the second blank check company formed by EcoR1 Capital targeting the biotech industry, filed on Tuesday with the SEC to raise up to $150 million in an initial public offering.
Panacea Acquisition Corp. II has filed to go public with an IPO on the NASDAQ.
Panacea Acquisition II is a newly incorporated blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While we may pursue an initial business combination opportunity in any industry or geographical location, we intend to capitalize on our management team’s background and experience to identify innovative companies in the biotechnology sector that are domiciled in North America or Europe. Our sponsor i... [Read more...]
|IPO Date |
Apr 7, 2021
|Stock Exchange |
|Ticker Symbol |